By Max Braht, VP of Business Development, LSN
Last week, I wrote about why successful fundraising requires a focused strategy and consistent execution (see last week’s article here). But even the strongest opportunity needs to reach the right audience. Companies must identify between 600-800+ investor and licensing partner targets whose investment thesis align with their technology and stage of development. Companies must then be able to effectively communicate a compelling value proposition and maintain structured outreach long enough to generate a first meeting. This process is not easy, it is not fast, and it is not optional.
LSN’s BD Assist program is designed to remove the daily work required to push your fundraising campaign forward. By handling the messaging, canvassing, outreach, scheduling, and more – BD Assist allows you to focus on product development, regulatory hurdles, and other operational complexities of running your company.
Timing
The life sciences industry has shifted into JPM Healthcare Conference preparation mode, as biotech, medtech, healthcare, and investment professionals from around the world prepare to gather for one of the industry’s most important networking events – with RESI JPM serving as the epicenter for early-stage partnering.
However, the goal should not simply be to fill a meeting calendar. Companies must aim to connect with the right partners and build relationships that advance fundraising and licensing objectives in the months and years ahead.
RESI JPM creates access, but it is sustained execution that turns that access into opportunity. Companies that maintain targeted outreach and consistent follow-up before, during, and after the conference will be better positioned to build lasting relationships and translate initial conversations into meaningful business development outcomes.
Ready to accelerate your fundraising?
Contact salescore@lifesciencenation.com to learn how LSN’s BD Assist can help you connect with the right investors and advance your fundraising goals.
| Get Your LSN Labs Company Assessment Report |
